CRVS - Company ID 0001626971
Corvus Pharmaceuticals, Inc. trades as CRVS and has a market capitalization of $1.32 B, making it the #2451 largest US-listed company by market value. This page tracks Corvus Pharmaceuticals, Inc. through 570 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
2026-07-10
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-20 |
| SCHEDULE 13G/A | - | 2026-05-15 |
| SCHEDULE 13G | - | 2026-05-15 |
| Major company event | 8-K | 2026-05-14 |
| Major company event | 8-K | 2026-05-07 |
| Employee stock plan | S-8 | 2026-05-07 |
| Quarterly report | 10-Q | 2026-05-07 |
| SCHEDULE 13G/A | - | 2026-04-27 |
The largest companies sharing Corvus Pharmaceuticals, Inc.'s SEC industry classification (pharmaceutical preparations).
Corvus Pharmaceuticals, Inc. (CRVS) has a market capitalization of $1.32 B as of 2026-07-10, ranking #2451 among US-listed companies.
In its latest fiscal year Corvus Pharmaceuticals, Inc. reported a net loss of $15.30M.